Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBITDA Margin: 2010-2025

Historic EBITDA Margin for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to 7.78%.

  • Mesa Laboratories' EBITDA Margin rose 171.00% to 7.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.13%, marking a year-over-year increase of 12097.00%. This contributed to the annual value of 6.78% for FY2025, which is 13263.00% up from last year.
  • Per Mesa Laboratories' latest filing, its EBITDA Margin stood at 7.78% for Q3 2025, which was up 51.15% from 5.15% recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' EBITDA Margin ranged from a high of 11.72% in Q3 2021 and a low of -460.55% during Q1 2024.
  • Moreover, its 3-year median value for EBITDA Margin was 2.36% (2025), whereas its average is -38.28%.
  • As far as peak fluctuations go, Mesa Laboratories' EBITDA Margin tumbled by 46,148bps in 2024, and later skyrocketed by 46,292bps in 2025.
  • Mesa Laboratories' EBITDA Margin (Quarterly) stood at -4.59% in 2021, then spiked by 1,086bps to 6.27% in 2022, then tumbled by 639bps to -0.13% in 2023, then surged by 932bps to 9.20% in 2024, then soared by 171bps to 7.78% in 2025.
  • Its last three reported values are 7.78% in Q3 2025, 5.15% for Q2 2025, and 2.36% during Q1 2025.